Thyroid Eye Disease (TED) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share

What industry-specific factors are fueling the growth of the thyroid eye disease (ted) market?
The increasing occurrence of thyroid disorders is expected to drive the expansion of the thyroid eye disease (TED) market in the future. Thyroid disorders are medical conditions that affect the thyroid gland's function, leading to hormonal imbalances that cause conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rise in thyroid disorders is attributed to factors such as increased iodine intake, autoimmune diseases, genetic factors, and greater awareness leading to improved diagnosis rates. Thyroid Eye Disease (TED) is a common complication of Graves' disease, which contributes to the growing awareness and incidence of thyroid-related conditions. For example, in May 2024, the Canadian Cancer Society projected that 6,600 new thyroid cancer cases would be diagnosed in Canada in 2024, with about 280 expected fatalities. Therefore, the increasing prevalence of thyroid disorders is driving the growth of the thyroid eye disease (TED) market.

Get Your Thyroid Eye Disease (TED) Market Report Here:
https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

What Is the projected market size and growth rate for the thyroid eye disease (ted) market?
The thyroid eye disease (TED) market has expanded significantly, growing from $2.15 billion in 2024 to $2.30 billion in 2025 at a CAGR of 7.0%. This growth is driven by rising thyroid disorders, an increased focus on patient-centered care, greater demand for cosmetic procedures, a higher prevalence of TED, and expanding treatment options.

The thyroid eye disease (TED) market is projected to witness substantial growth, reaching $2.97 billion by 2029, with a CAGR of 6.6%. Growth drivers include the rising prevalence of Graves' disease, increasing investments across various industries, growing healthcare expenditures, greater use of thyroid hormone replacement therapy, and an increasing incidence of thyroid-related disorders. Major trends anticipated in this period include advancements in technology, expanding R&D efforts, the introduction of novel drug therapies, enhanced treatment options, and new surgical techniques.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

What new trends are reshaping the thyroid eye disease (ted) market and its opportunities?
In the thyroid eye disease (TED) market, companies are focusing on innovative treatments such as monoclonal antibody therapies to improve patient outcomes. These therapies use laboratory-made antibodies to target specific components of the immune system, reducing inflammation and other TED symptoms. For example, in September 2024, Amgen Inc. received approval from Japan's Ministry of Health for TEPEZZA (teprotumumab), the first FDA-approved therapy specifically for TED. This approval offers a targeted solution for patients with active thyroid eye disease, helping to reduce symptoms like eye bulging, pain, and vision problems.

What major market segments define the scope and growth of the thyroid eye disease (ted) market?
The thyroid eye disease (TED) market covered in this report is segmented -

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical
2) By Disease Severity: Mild, Moderate, Severe
3) By Drug Type: Biologics, Small Molecules, Others Drug Type
4) By Route Of Administration: Oral, Intravenous, Subcutaneous
5) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300

Which region dominates the thyroid eye disease (ted) market?
North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the thyroid eye disease (ted) industry growth?
Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

What Is Covered In The Thyroid Eye Disease (TED) Global Market Report?

•Market Size Forecast: Examine the thyroid eye disease (ted) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the thyroid eye disease (ted) market for a structured understanding.
•Key Players Overview: Analyze major players in the thyroid eye disease (ted) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the thyroid eye disease (ted) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the thyroid eye disease (ted) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the thyroid eye disease (ted) market.
•Industry Challenges: Identify potential risks and obstacles affecting the thyroid eye disease (ted) market.
•Competitive Landscape: Review strategic developments in the thyroid eye disease (ted) market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.